144 related articles for article (PubMed ID: 10449674)
21. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
Chattopadhyay A; Chawda JG; Doshi JJ
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
24. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Saintigny P; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim ES; Hong WK; Lippman SM; Mao L
Clin Cancer Res; 2009 Oct; 15(19):6284-91. PubMed ID: 19773378
[TBL] [Abstract][Full Text] [Related]
25. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1083-9. PubMed ID: 10522499
[TBL] [Abstract][Full Text] [Related]
26. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
Benner SE; Wargovich MJ; Lippman SM; Fisher R; Velasco M; Winn RJ; Hong WK
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):73-6. PubMed ID: 8118389
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.
Shirasuna K; Hayashido Y; Sugiyama M; Yoshioka H; Matsuya T
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):349-53. PubMed ID: 2024456
[TBL] [Abstract][Full Text] [Related]
28. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
29. Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.
Zeng Q; Smith DC; Suscovich TJ; Gooding WE; Trump DL; Grandis JR
Clin Cancer Res; 2000 Jun; 6(6):2245-51. PubMed ID: 10873074
[TBL] [Abstract][Full Text] [Related]
30. Predicting cancer development in oral leukoplakia: ten years of translational research.
Lee JJ; Hong WK; Hittelman WN; Mao L; Lotan R; Shin DM; Benner SE; Xu XC; Lee JS; Papadimitrakopoulou VM; Geyer C; Perez C; Martin JW; El-Naggar AK; Lippman SM
Clin Cancer Res; 2000 May; 6(5):1702-10. PubMed ID: 10815888
[TBL] [Abstract][Full Text] [Related]
31. bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study.
Piattelli A; Fioroni M; Santinelli A; Rubini C
Oral Oncol; 1999 May; 35(3):314-20. PubMed ID: 10621853
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.
Prime SS; Game SM; Matthews JB; Stone A; Donnelly MJ; Yeudall WA; Patel V; Sposto R; Silverthorne A; Scully C
Br J Cancer; 1994 Jan; 69(1):8-15. PubMed ID: 8286215
[TBL] [Abstract][Full Text] [Related]
33. Oral lichen planus treated with 13-cis-retinoic acid (isotretinoin): effects on the apoptotic process.
Piattelli A; Carinci F; Iezzi G; Perrotti V; Goteri G; Fioroni M; Rubini C
Clin Oral Investig; 2007 Sep; 11(3):283-8. PubMed ID: 17483968
[TBL] [Abstract][Full Text] [Related]
34. Use of antioxidant supplements in the treatment of human oral leukoplakia.
Kaugars GE; Silverman S; Lovas JG; Thompson JS; Brandt RB; Singh VN
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):5-14. PubMed ID: 8850475
[TBL] [Abstract][Full Text] [Related]
35. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
36. Results, toxicity and compliance in chemoprevention trials of head and neck cancer.
Toma S; Palumbo R; Rosso R
Eur J Cancer Prev; 1994 Jan; 3(1):63-8. PubMed ID: 8130719
[TBL] [Abstract][Full Text] [Related]
37. Expression of epidermal growth factor receptor and transforming growth factor alpha in human larynx carcinoma.
Di Marco E; Albanese E; Benso S; Beatrice F; Cancedda R; Toma S
Cancer Lett; 1992 Aug; 65(3):189-99. PubMed ID: 1516034
[TBL] [Abstract][Full Text] [Related]
38. Expression of alpha(v)beta6 integrin in oral leukoplakia.
Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
[TBL] [Abstract][Full Text] [Related]
39. TGF-alpha and oral carcinogenesis.
Wong DT
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):3-7. PubMed ID: 8180574
[TBL] [Abstract][Full Text] [Related]
40. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
Filipe MI; Osborn M; Linehan J; Sanidas E; Brito MJ; Jankowski J
Br J Cancer; 1995 Jan; 71(1):30-6. PubMed ID: 7819044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
